Clinical Trial Update: A Phase II/III Trial to Evaluate the Efficacy and Safety of Surufatinib Combined With Camrelizumab, Nab-paclitaxel, and Gemcitabine in Metastatic Pancreatic Cancer [Phase 2, Phase 3]

View source ↗

Summary

This clinical trial update describes a Phase II/III study evaluating the efficacy and safety of Surufatinib in combination with Camrelizumab, Nab-paclitaxel, an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Camrelizumab (camrelizumab)
• Gemcitabine (Gemcitabine)
• Surufatinib (Surufatinib)

Snippet

Sponsor: Hutchmed | Conditions: Metastatic Pancreatic Cancer | Phase 2, Phase 3 | Status: RECRUITING